Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$62.17 - $97.62 $208,269 - $327,027
-3,350 Reduced 4.36%
73,523 $7.18 Million
Q4 2022

Feb 10, 2023

BUY
$60.21 - $77.74 $1.28 Million - $1.65 Million
21,182 Added 38.03%
76,873 $4.78 Million
Q3 2022

Oct 24, 2022

BUY
$72.92 - $99.73 $4.06 Million - $5.55 Million
55,691 New
55,691 $4.06 Million
Q1 2020

May 14, 2020

SELL
$52.76 - $109.0 $9.15 Million - $18.9 Million
-173,348 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$69.39 - $97.59 $264,098 - $371,427
3,806 Added 2.24%
173,348 $16.6 Million
Q3 2019

Nov 12, 2019

BUY
$64.17 - $84.08 $153,173 - $200,698
2,387 Added 1.43%
169,542 $12 Million
Q2 2019

Aug 07, 2019

BUY
$70.1 - $85.17 $272,548 - $331,140
3,888 Added 2.38%
167,155 $14.2 Million
Q1 2019

May 13, 2019

BUY
$77.0 - $99.34 $12.6 Million - $16.2 Million
163,267 New
163,267 $13.9 Million

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.